Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
0 views
•
2019
•
Cited by 3
•
Cancer ResearchFilters
Show Articles
Date
Author

0 views
•
2019
•
Cited by 3
•
Cancer Research
0 views
•
2017
•
Cited by 5
•
Cancer Research
Copyright © 2026 MyJoVE Corporation. All rights reserved.